Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JM Integrated Health vs Layla

JM Integrated Health
Graded #428

Lower grade

vs+15.000000000000007
Layla
Graded #103

Higher grade

The verdict

Layla takes it — 70.9/100 to 55.9/100.

Layla grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLayla +21
45
66
Dose & formulationLayla +43
53
96
Clinical oversightJM Integrated Health +13
89
76
Labs & monitoringJM Integrated Health +1
53
52
FulfillmentLayla +9
56
65
Contract termsLayla +35
20
55
JM Integrated Health · left barLayla · right bar

The numbers

MetricJM Integrated HealthLayla
WeighScore55.9/10070.9/100
GradeCC
Scorecard rank#428#103
SemaglutideNot disclosed$237/mo (all doses, compounded)
TirzepatideNot disclosed$199/mo (all doses, compounded)
Coverage6 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
JM Integrated Health

Graded #428 · C

Strengths

  • Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
  • Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
  • Six states clearly listed (TX, VT, NM, AZ, WA, NV)
  • Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
  • Publishes the FDA compounded-medication disclaimer

Where it loses points

  • 503A pharmacy partner not named publicly
  • Single-provider practice — enrollment is capacity-limited
  • Only six states served, vs nationwide competitors
  • Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
  • No LegitScript certification displayed
Layla

Graded #103 · C

Strengths

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where it loses points

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard